In addition to country-specific data, decision-makers will require global-level information—that is, information not specific to their countries. This includes data on the vaccine’s cost and efficacy (which should become available during Phase 3 clinical trials). The planning tool presents this global-level data in brown boxes, also arranged by time period and by category.

Download the planning tool (1.6 MB PDF)